| Primary |
| Atrial Fibrillation |
45.5% |
| Hypertension |
15.5% |
| Cerebrovascular Accident Prophylaxis |
5.2% |
| Blood Cholesterol Increased |
5.0% |
| Prophylaxis |
3.5% |
| Supplementation Therapy |
3.0% |
| Diabetes Mellitus |
2.9% |
| Cardiac Disorder |
2.9% |
| Anticoagulant Therapy |
2.6% |
| Thrombosis Prophylaxis |
2.1% |
| Hypothyroidism |
2.0% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Cardiac Failure Congestive |
1.2% |
| Routine Health Maintenance |
1.1% |
| Pain |
1.1% |
| Depression |
1.0% |
| Cardiac Failure |
1.0% |
| Chronic Obstructive Pulmonary Disease |
0.9% |
| Anxiety |
0.9% |
| Insomnia |
0.8% |
|
| Gastrointestinal Haemorrhage |
20.0% |
| Cerebrovascular Accident |
11.1% |
| Haemorrhage |
8.8% |
| Death |
7.1% |
| Rectal Haemorrhage |
5.0% |
| Deep Vein Thrombosis |
4.2% |
| Dizziness |
4.1% |
| Ischaemic Stroke |
3.9% |
| Headache |
3.7% |
| Dyspepsia |
3.7% |
| Pulmonary Embolism |
3.6% |
| Haemorrhage Intracranial |
3.4% |
| Transient Ischaemic Attack |
3.2% |
| International Normalised Ratio Increased |
3.1% |
| Myocardial Infarction |
3.0% |
| Dyspnoea |
2.5% |
| Nausea |
2.5% |
| Diarrhoea |
2.5% |
| Oedema Peripheral |
2.5% |
| Fall |
2.3% |
|
| Secondary |
| Atrial Fibrillation |
36.3% |
| Cerebrovascular Accident Prophylaxis |
13.1% |
| Hypertension |
12.6% |
| Anticoagulant Therapy |
5.2% |
| Product Used For Unknown Indication |
4.2% |
| Blood Cholesterol Increased |
3.7% |
| Prophylaxis |
3.3% |
| Cardiac Disorder |
3.0% |
| Thrombosis Prophylaxis |
2.6% |
| Supplementation Therapy |
2.5% |
| Diabetes Mellitus |
2.4% |
| Hypothyroidism |
1.7% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Pain |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Cardiac Failure Congestive |
1.3% |
| Cerebrovascular Accident |
1.2% |
| Atrial Flutter |
1.0% |
| Routine Health Maintenance |
0.9% |
| Arrhythmia |
0.9% |
|
| Gastrointestinal Haemorrhage |
16.6% |
| Death |
12.8% |
| Cerebrovascular Accident |
9.4% |
| Rectal Haemorrhage |
6.9% |
| Ischaemic Stroke |
4.3% |
| Upper Gastrointestinal Haemorrhage |
4.2% |
| Haemorrhage |
4.0% |
| Pulmonary Embolism |
4.0% |
| Renal Failure Acute |
3.9% |
| Dizziness |
3.5% |
| Dyspepsia |
3.5% |
| Myocardial Infarction |
3.3% |
| Deep Vein Thrombosis |
3.3% |
| Transient Ischaemic Attack |
3.2% |
| Pneumonia |
3.0% |
| Headache |
2.9% |
| Vomiting |
2.9% |
| Nausea |
2.9% |
| Renal Impairment |
2.8% |
| Lower Gastrointestinal Haemorrhage |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.2% |
| Atrial Fibrillation |
14.4% |
| Hypertension |
9.3% |
| Pulmonary Arterial Hypertension |
3.7% |
| Anticoagulant Therapy |
3.3% |
| Cardiac Disorder |
3.3% |
| Rheumatoid Arthritis |
3.0% |
| Gastrooesophageal Reflux Disease |
2.9% |
| Chronic Obstructive Pulmonary Disease |
2.6% |
| Blood Cholesterol Increased |
2.5% |
| Drug Use For Unknown Indication |
2.4% |
| Pain |
2.3% |
| Type 2 Diabetes Mellitus |
2.3% |
| Osteoporosis |
1.9% |
| Diabetes Mellitus |
1.8% |
| Blood Pressure |
1.7% |
| Depression |
1.7% |
| Arrhythmia |
1.6% |
| Prophylaxis |
1.5% |
| Epididymitis |
1.4% |
|
| Atrial Fibrillation |
11.2% |
| Drug Ineffective |
8.1% |
| Weight Decreased |
7.8% |
| Cerebrovascular Accident |
5.8% |
| Death |
5.0% |
| Pneumonia |
5.0% |
| Dyspnoea |
4.7% |
| Headache |
4.7% |
| Nausea |
4.7% |
| Off Label Use |
4.7% |
| Renal Failure Acute |
4.7% |
| Bronchiectasis |
4.3% |
| Visual Impairment |
4.3% |
| Vomiting |
4.3% |
| Blood Glucose Increased |
3.9% |
| Pruritus |
3.9% |
| Pain |
3.5% |
| Rash |
3.5% |
| Insomnia |
3.1% |
| Oedema Peripheral |
3.1% |
|
| Interacting |
| Atrial Fibrillation |
26.7% |
| Product Used For Unknown Indication |
12.4% |
| Pain |
10.0% |
| Hypertension |
7.2% |
| Thrombosis Prophylaxis |
6.4% |
| Prophylaxis Against Gastrointestinal Ulcer |
5.2% |
| Cardiac Failure Chronic |
3.6% |
| Procedural Nausea |
3.2% |
| Type 2 Diabetes Mellitus |
3.2% |
| Hypercholesterolaemia |
2.8% |
| Arrhythmia |
2.4% |
| Cardiomyopathy |
2.4% |
| Insomnia |
2.4% |
| Angina Pectoris |
2.0% |
| Atrial Flutter |
2.0% |
| Diabetes Mellitus |
2.0% |
| Anticoagulant Therapy |
1.6% |
| Cardiac Failure |
1.6% |
| Diuretic Therapy |
1.6% |
| Urinary Tract Infection |
1.6% |
|
| Drug Interaction |
17.5% |
| Renal Failure |
17.5% |
| Rectal Haemorrhage |
15.9% |
| Syncope |
6.3% |
| Gastrointestinal Haemorrhage |
4.8% |
| Haematoma |
4.8% |
| Melaena |
4.8% |
| Epistaxis |
3.2% |
| Overdose |
3.2% |
| Pulmonary Embolism |
3.2% |
| Skin Haemorrhage |
3.2% |
| Thrombosis |
3.2% |
| Actinic Keratosis |
1.6% |
| Conjunctival Haemorrhage |
1.6% |
| Deep Vein Thrombosis |
1.6% |
| Haemorrhage Urinary Tract |
1.6% |
| Hypertension |
1.6% |
| Hypovolaemic Shock |
1.6% |
| Inhibitory Drug Interaction |
1.6% |
| International Normalised Ratio Increased |
1.6% |
|
